THE DEFINITIVE GUIDE TO PHARMACEUTICAL INGREDIENTS

“The current scenario has exposed some structural weaknesses from the EU’s medicines offer chain as well as a superior dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides said. She proposed that provide chain difficulties be resolved within an EU pharmaceutical strategy anticipated being introduced